You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

fludarabine

Showing 51 - 75 of 741
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sickle Cell Disease Trial in Hackensack (Alemtuzumab, Fludarabine, Melphalan)

Active, not recruiting
  • Sickle Cell Disease
  • Hackensack, New Jersey
    Hackensack University Medical Center
Feb 4, 2022

AML, Adult, Minimal Residual Disease Trial in Tianjin (CD33/CLL1 dual CAR-NK cell, Cyclophosphamid, Fludarabine)

Not yet recruiting
  • AML, Adult
  • Minimal Residual Disease
  • CD33/CLL1 dual CAR-NK cell
  • +5 more
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Aug 4, 2023

Lupus Erythematosus, Systemic Trial in Berlin (CC-97540, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • Lupus Erythematosus, Systemic
  • Berlin, Germany
    Local Institution - 0025
May 22, 2023

Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

Not yet recruiting
  • Non-hodgkin Lymphoma
  • +9 more
  • CD79b-19 CAR T cells
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 6, 2023

AML, Adult Trial in Hangzhou (QN-030a, Cyclophosphamid, Fludarabine)

Recruiting
  • AML, Adult
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Dec 29, 2022

Acute B Lymphoblastic Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Shanghai (Fludarabine)

Recruiting
  • Acute B Lymphoblastic Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Fludarabine
  • Shanghai, China
    Shanghai General Hospital
May 13, 2022

B-cell Lymphoma Trial in Stockholm, Uppsala (CAR20(NAP)-T, Cyclophosphamide, Fludarabine)

Not yet recruiting
  • B-cell Lymphoma
  • CAR20(NAP)-T
  • +2 more
  • Stockholm, Sweden
  • +1 more
Aug 15, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Leukemia
  • (no location specified)
Nov 30, 2022

Acute Myeloid Leukemia, Pediatric Cancer Trial in Boston (Uproleselan, Fludarabine, Clofarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Pediatric Cancer
  • Boston, Massachusetts
  • +1 more
Oct 24, 2022

AML, Adult Trial in Tianjin (QN-023a, Cyclophosphamid, Fludarabine)

Recruiting
  • AML, Adult
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Nov 3, 2022

Minimal Residual Disease Trial in Tianjin (QN-030a, Cyclophosphamid, Fludarabine)

Recruiting
  • Minimal Residual Disease
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Nov 3, 2022

Nasopharyngeal Carcinoma Trial in Xuzhou (CAR-T Cell Injection, Fludarabine, cyclophosphamide)

Recruiting
  • Nasopharyngeal Carcinoma
  • CAR-T Cell Injection
  • +2 more
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Dec 15, 2022

GATA2, Immunodeficiency Trial run by the National Cancer Institute (NCI) (drug, radiation, procedure)

Not yet recruiting
  • GATA2
  • Immunodeficiency
  • Mycophenolate Mofetil
  • +7 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 23, 2023

Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

Recruiting
  • Stem Cell Transplant Complications
  • +4 more
  • Radiation
  • +7 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Nasopharyngeal Carcinoma Trial in Xuzhou (BGT007 Cell Injection, Fludarabine, cyclophosphamide)

Recruiting
  • Nasopharyngeal Carcinoma
  • BGT007 Cell Injection
  • +2 more
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Dec 14, 2022

Solid Tumors Trial (TCR-T cells, Fludarabine, Cyclophosphamide Capsules)

Not yet recruiting
  • Solid Tumors
  • TCR-T cells
  • +4 more
  • (no location specified)
Dec 12, 2022

Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,

Active, not recruiting
  • Acute Leukemia
  • +4 more
  • Fludarabine
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Advanced Solid Tumors Trial in Chongqing (TC-N201 cells, IL-2, Fludarabine)

Recruiting
  • Advanced Solid Tumors
  • TC-N201 cells
  • +4 more
  • Chongqing, China
    TCRCure Biopharma Ltd.
May 25, 2023

Sarcoma Trial in Houston (Autologous HER2-specific T cells, Fludarabine, Cyclophosphamide)

Active, not recruiting
  • Sarcoma
  • Autologous HER2-specific T cells
  • +3 more
  • Houston, Texas
  • +1 more
Nov 21, 2022

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Sentinel Lymph Node Biopsy (SLNB)
  • +7 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 2, 2023

AML, Adult Trial in Hangzhou (QN-023a, Cyclophosphamid, Fludarabine)

Recruiting
  • AML, Adult
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Dec 29, 2022

Myelogenous Leukemia, Acute Trial in Ramat Gan (Bisantrene, Fludarabine, Clofarabine)

Recruiting
  • Myelogenous Leukemia, Acute
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
Sep 21, 2021

Neuroblastoma Trial in Houston (GINAKIT Cells, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Neuroblastoma
  • GINAKIT Cells
  • +2 more
  • Houston, Texas
    Texas Children's Hospital
Jan 18, 2023

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Surgery for harvesting tumor-draining lymph nodes
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 2, 2023

Aplastic Anemia, Neutropenia, Pancytopenia Trial run by the NHLBI (Cyclophosphamide, Fludarabine)

Completed
Has Results
  • Aplastic Anemia
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 7, 2021